Literature DB >> 19723033

Neuronal apoptosis in Alzheimer's disease: the role of age-related mitochondrial metabolic competence.

Carlo Bertoni-Freddari1, Patrizia Fattoretti, Tiziana Casoli, Giuseppina Di Stefano, Marta Balietti, Belinda Giorgetti, Gemma Perretta.   

Abstract

To assess the role of the mitochondrial metabolic competence (MMC) in the development of age-related changes, we measured the levels of immunohistochemically stained (IH) mitochondrial- and nuclear-encoded subunits of cytochrome oxidase (COX II and COX IV, respectively) and compared these data with mRNA in situ hybridization (ISH) of the same subunits and with cytochemically evidenced COX activity in the temporal (TC) and frontal (FC) cortex of adult and late-adult monkeys. Quantitative cytochemistry of COX activity was performed by calculating the ratio (R) of the area of the cytochemical precipitate to the area of the respective organelle. Although ISH studies showed reduced gene expression of both subunits in FC of late-adult monkeys, no significant age-related difference was found either in TC or FC when considering the IH data. R was significantly increased in FC of late-adult animals, and a quartile distribution of the mitochondrial area showed that R is higher in the FC of older animals independent of the organelle size. The assessment of COX genetic and phenotypic parameters reliably reports on MMC because this enzyme is the terminal complex of the electron transport chain. Taken together, the present IH, ISH, and R findings suggest that, with advancing age, compensating mechanisms are activated to preserve the mitochondrial functional metabolic capacities. Although significant mitochondrial defects are currently reported to occur in Alzheimer's disease pathogenesis, our data document that MMC is actively involved in the physiological rearrangement of the age-related neuronal network and may provide substantial metabolic support for the energy demand of neuronal apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723033     DOI: 10.1111/j.1749-6632.2009.04886.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms.

Authors:  Tourandokht Baluchnejadmojarad; Seyed-Mahdi Mohamadi-Zarch; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2019-08-17       Impact factor: 3.584

Review 2.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

Review 3.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

Review 4.  Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.

Authors:  Chun Shi; Jun Liu; Fengming Wu; David T Yew
Journal:  Int J Mol Sci       Date:  2010-01-08       Impact factor: 5.923

5.  Identification and Analysis of Alzheimer's Candidate Genes by an Amplitude Deviation Algorithm.

Authors:  Chaoyang Pang; Hualan Yang; Benqiong Hu; Shipeng Wang; Meixia Chen; David S Cohen; Hannah S Chen; Juliet T Jarrell; Kristy A Carpenter; Eric R Rosin; Xudong Huang
Journal:  J Alzheimers Dis Parkinsonism       Date:  2019-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.